How many insider declarations has Stahlberg Jan filed?

Stahlberg Jan has filed 2 public insider declarations with SEC (Form 4).

What is Stahlberg Jan's role?

Stahlberg Jan's reported role is not specified by the regulator across the filings.

Which companies does Stahlberg Jan report trades for?

Stahlberg Jan reports trades for DiaMedica Therapeutics Inc..

What is Stahlberg Jan's declared buy vs sell volume?

Across the available history, declared buys total 7.4M€ and disposals 0.

← Executives ★ Sign in to follow

SJ

Stahlberg Jan

·SEC (Form 4)

DiaMedica Therapeutics Inc.

0

Total declarations

0

Company

€7m

▲ Purchases (2 ops.)

—

▼ Sales (0 ops.)

Insider track record

Other

Disclosed buys

2

Disclosed sells

0

T+90 hit rate

100%

T+90 mean return

+33.2%

Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.

Signal history

No signal scores available.

Browse the full record of transactions filed by Stahlberg Jan. Director active across 1 company, notably DiaMedica Therapeutics Inc.. In total, 2 reports have been recorded. Split: 2 buys · 0 sell. Total volume traded: €7.4m. History available since 28 June 2024. The latest transaction was disclosed on 23 July 2025 (Acquisition). Regulator: SEC (Form 4). The full history is accessible without signup.

Companies and markets linked to Stahlberg Jan

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

DiaMedica Therapeutics Inc. (US)

Declarations2 total

▲

STAHLBERG JAN

Executives23 Jul 2025DiaMedica Therapeutics Inc.

$5M0SEC ↗

1,542,857 shares@ US$3.50Common SharesSEC:0001104659-25-070920:0

Canonical exit: 21 Oct 2025 (T+90)

▲